Insider · CIK 0002102118
Benjamin Bruno Thorner
Files at EIKN (Eikon Therapeutics, Inc.). First filing -, latest -.
In brief
Benjamin Bruno Thorner files SEC Form 4 as officer at EIKN (Eikon Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Benjamin Bruno Thorner has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | EIKN Eikon Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +67,044 | $0.00 | $0 | 67,044 | Mar 4, 2026 |
Questions about Benjamin Bruno Thorner
Answered from the filings on this page, as of the latest one.
Is Benjamin Bruno Thorner buying or selling?
Benjamin Bruno Thorner has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Benjamin Bruno Thorner's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Benjamin Bruno Thorner has 0.
Where does Benjamin Bruno Thorner file Form 4?
Benjamin Bruno Thorner has filed Form 4 at EIKN (Eikon Therapeutics, Inc.) as See Remarks. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.